BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Ajinomoto CELLiST Korea Launches New CELLiST AAV Production Supplement 1 to Boost Viral Vector Productivity

Ajinomoto Co in Tokyo collaborated with its United States based consolidated subsidiary Forge Biologics, a leading CDMO in adeno associated virus developme...

December 04, 2025 | News

Imugene and JW Therapeutics Launch First-in-Class “Mark and Kill” Solid Tumor Collaboration

Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytic...

December 01, 2025 | News

Juventas’ CAR-T Therapy Ina-cel Receives NMPA Approval for Large B-Cell Lymphoma

Juventas Cell Therapy Co., Ltd. (hereinafter referred to as "Juventas") announced that its independently developed CAR-T cell therapy product, Inatica...

December 01, 2025 | News

IASO Bio Achieves Landmark Hong Kong Approval for Fucaso CAR-T Therapy

IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company dedicated to the discovery, development, manufacturing, and commerciali...

November 28, 2025 | Regulatory

eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing

eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, throug...

November 27, 2025 | News

Global Leaders Signal a Confident New Chapter for Cell and Gene Therapy at GenScript Global Forum London 2025

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...

November 24, 2025 | News

Thermo Fisher Opens Advanced Therapies Collaboration Center In Philadelphia To Accelerate Cell And Gene Therapy Development

New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies ...

November 19, 2025 | News

Terumo BCT Achieves Breakthrough in Automated T Cell Therapy Manufacturing

Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, announced an advancement in T cell therapy manufact...

November 19, 2025 | News

Evonik and InVitria Partner to Expand Global Supply of Animal Component-Free Recombinant HSA

Expanded supply of animal component-free human serum albumin for advanced therapies and next-generation biopharmaceutical processes Safer, more consiste...

November 18, 2025 | News

Leucid Bio Reports Proof-of-Concept for LEU011 CAR-T Therapy in Solid Tumours from Ongoing AERIAL Trial

Proof-of-concept established for LEU011 in the treatment of relapsed/refractory solid tumours LEU011 has been well tolerated, with disease control obser...

November 11, 2025 | News

CorrectSequence Therapeutics Achieves World’s First Gene-Editing Success in Hyperlipidaemia Treatment

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy On&n...

November 07, 2025 | News

Nona Biosciences Expands Partnership with Umoja Biopharma to Advance Next-Generation In Vivo CAR-T Therapies

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), announced an evaluation and licen...

November 06, 2025 | News

Bio-Techne and Nucleai Demonstrate Predictive Power of Spatial Biomarkers in Melanoma

Clinical trial data demonstrates how Bio-Techne's spatial biology technology and Nucleai's AI-powered multimodal platforms can identify predictive biomar...

November 05, 2025 | News

4D Molecular Therapeutics and Otsuka Form $471 Million Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacific

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...

November 04, 2025 | News

Stay Connected